SFX by Ex Libris Inc.

Title:	Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Source:	Nature [0028-0836] Kim, S yr:2009

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Balkwill, F. "Tumour necrosis factor and cancer." Nature Reviews. Cancer 9.5 (2009): 361-371.
description	2.	Gariboldi, S.. "Low molecular weight hyaluronic acid increases the self-defense of skin epithelium by induction of beta-defensin 2 via TLR2 and TLR4." The journal of immunology 181.3 (2008): 2103-2110.
description	3.	Mantovani, A. "CANCER Inflaming metastasis." Nature 457.7225 (2009): 36-37.
description	4.	Malanchi, I. "Cancer stem cells: never Wnt away from the niche." Current opinion in oncology 21.1 (2009): 41-46.
description	5.	van der Pouw Kraan, T C T M C. "Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients." Annals of the rheumatic diseases 66.8 (2007): 1008-14.
description	6.	Balkwill, F. "TNF-(alpha) in promotion and progression of cancer." Cancer and metastasis reviews 25.3 (2006): 409-416.
description	7.	Waters, John P. "Tumour necrosis factor and cancer." The Journal of pathology 00230.00003 (2013): 241-248.
description	8.	Anderson, G Mark M. "Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer." Current opinion in pharmacology 4.4 (2004): 314-320.
description	9.	Mantovani, A. "Cancer-related inflammation." Nature 454.7203 (2008): 436-44.
description	10.	Shimada, JoAnne S. "Hyaluronan fragments generated by sperm-secreted hyaluronidase stimulate cytokine/chemokine production via the TLR2 and TLR4 pathway in cumulus cells of ovulated COCs, which may enhance fertilization." Development 135.11 (2008): 11-11.
description	11.	Weissleder, Mikael J J. "Imaging in the era of molecular oncology." Nature 452.7187 (2008): 580-9.
description	12.	Joris, I. "Apoptosis, oncosis, and necrosis. An overview of cell death." The American journal of pathology 146.1 (1994): 3-15.
description	13.	Mantovani, A. "Inflammation and cancer: back to Virchow?" Lancet, The 357.9255 (2001): 539-45.
description	14.	Yu, J. "Noncanonical NF-κB Activation Mediates STAT3-Stimulated IDO Upregulation in Myeloid-Derived Suppressor Cells in Breast Cancer." The journal of immunology 193.5 (2014): 2574-2586.
description	15.	Farwick, M. "Fifty-kDa Hyaluronic Acid Upregulates Some Epidermal Genes without Changing TNF-? Expression in Reconstituted Epidermis." Skin pharmacology and physiology 24.4 (2011): 210-217.
description	16.	Villanueva, J. "Melanoma and the tumor microenvironment." Current Oncology Reports 10.5 (2008): 439-46.
description	17.	Dunn, Gavin P P. "The immunobiology of cancer immunosurveillance and immunoediting." Immunity 21.2 (2004): 137-148.
description	18.	Johns, D B B. "Reduction of adhesion formation by postoperative administration of ionically cross-linked hyaluronic acid." Fertility and sterility 68.1 (1997): 37-42.
description	19.	Hannuksela, A. "Psoriasis, its treatment, and cancer in a cohort of Finnish patients." The Journal of investigative dermatology 114.3 (2000): 587-590.
description	20.	Girish, K S S. "The magic glue hyaluronan and its eraser hyaluronidase: a biological overview." Life Sciences 80.21 (2007): 1921-1943.